Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Nuclear Medicine

  Free Subscription


Articles published in Nucl Med Commun

Retrieve available abstracts of 253 articles:
HTML format



Single Articles


    November 2021
  1. CHEN Y, Qiu C, Yu W, Shao X, et al
    The relationship between brain glucose metabolism and insulin resistance in subjects with normal cognition - a study based on 18F-FDG PET.
    Nucl Med Commun. 2021 Nov 23. pii: 00006231-900000000-97951.
    PubMed     Abstract available


  2. LIN Z, Xue Q, Lin R, Yao S, et al
    Reference values of mandibular condylar growth activity: a study of SUVmax with quantitative bone SPECT/CT.
    Nucl Med Commun. 2021 Nov 15. pii: 00006231-900000000-97955.
    PubMed     Abstract available


  3. DONDI F, Albano D, Giubbini R, Bertagna F, et al
    18F-FDG PET/CT for the evaluation of male breast cancer: a systematic review.
    Nucl Med Commun. 2021 Nov 15. pii: 00006231-900000000-97954.
    PubMed     Abstract available


  4. COSKUN N, Cagdas B, Eroglu U, Aslan Y, et al
    The impact of 18F-fluorodeoxyglucose PET/computed tomography on clinical staging in bladder cancer.
    Nucl Med Commun. 2021 Nov 15. pii: 00006231-900000000-97953.
    PubMed     Abstract available


  5. ZHANG JH, Zhao J, Fan Y, Fu ZL, et al
    Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in patients with primary T cell lymphomas.
    Nucl Med Commun. 2021 Nov 15. pii: 00006231-900000000-97952.
    PubMed     Abstract available


    October 2021
  6. MCCONACHIE P, McKay E, Crane A, Nguyen N, et al
    Accurate measurement of coronary artery calcium in cancer patients using the CT component of PET/CT scans.
    Nucl Med Commun. 2021 Oct 27. pii: 00006231-900000000-97958.
    PubMed     Abstract available


  7. GUNDAVDA MK, Agarwal MG, Singh N, Gupta R, et al
    Can 18F-FDG PET/CT alone or combined with radiology be used to reliably grade cartilage bone neoplasms for surgical decision making?
    Nucl Med Commun. 2021 Oct 20. pii: 00006231-900000000-97961.
    PubMed     Abstract available


  8. TEILER J, Ahl M, Akerlund B, Brismar H, et al
    99mTc-HMPAO-WBC SPECT/CT versus 18F-FDG-WBC PET/CT in chronic prosthetic joint infection: a pilot study.
    Nucl Med Commun. 2021 Oct 20. pii: 00006231-900000000-97960.
    PubMed     Abstract available


  9. PAYNE H, Bomanji J, Bottomley D, Scarsbrook AF, et al
    Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy.
    Nucl Med Commun. 2021 Oct 19. pii: 00006231-900000000-97962.
    PubMed     Abstract available


  10. GUNDOGAN C, Komek H, Can C, Yildirim OA, et al
    Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
    Nucl Med Commun. 2021 Oct 5. pii: 00006231-900000000-97971.
    PubMed     Abstract available



  11. Evaluation of 68Ga-PSMA PET/CT with Volumetric Parameters for Staging of Prostate Cancer Patients: Erratum.
    Nucl Med Commun. 2021;42:1186.
    PubMed    



  12. British Nuclear Medicine Society Autumn Meeting 2021.
    Nucl Med Commun. 2021;42:1162-1185.
    PubMed    


  13. URBANO N, Scimeca M, Tavolozza M, Bonanno E, et al
    18F-FDG-PET/CT analysis in hospitalized patients affected by pulmonary disease: The experience of the Nuclear Medicine Unit of "Policlinico Tor Vegata".
    Nucl Med Commun. 2021;42:1104-1111.
    PubMed     Abstract available


    September 2021
  14. KARAHAN SEN NP, Aksu A, Bozkurt O, Tuna EB, et al
    Interreader agreement in evaluation of 68Ga-PSMA PET/CT at the time of initial staging: comparison of the three evaluation criteria in the pretreatment risk groups.
    Nucl Med Commun. 2021 Sep 23. pii: 00006231-900000000-97976.
    PubMed     Abstract available


  15. WANG M, Dong S, Zhang R, Sun D, et al
    Impact of reconstruction parameters on spatial resolution and its comparison between cadmium-zinc-telluride SPECT/CT and conventional SPECT/CT.
    Nucl Med Commun. 2021 Sep 23. pii: 00006231-900000000-97973.
    PubMed     Abstract available


    August 2021
  16. ICHIKAWA H, Onoguchi M, Shibutani T, Kato T, et al
    Optimization of cross-calibration factor for quantitative bone SPECT without attenuation and scatter correction in the lumbar spine: head-to-head comparison with attenuation and scatter correction.
    Nucl Med Commun. 2021 Aug 26. pii: 00006231-900000000-97979.
    PubMed     Abstract available


  17. JIANG C, Ma G, Liu Q, Song S, et al
    The value of preoperative 18F-FDG PET metabolic and volumetric parameters in predicting microvascular invasion and postoperative recurrence of hepatocellular carcinoma.
    Nucl Med Commun. 2021 Aug 26. pii: 00006231-900000000-97978.
    PubMed     Abstract available


  18. DONDI F, Albano D, Giubbini R, Bertagna F, et al
    18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review.
    Nucl Med Commun. 2021 Aug 26. pii: 00006231-900000000-97977.
    PubMed     Abstract available


  19. BAE SH, Kim JY, Jung EJ, Lee HS, et al
    The role of fluorodeoxyglucose-PET/computed tomography as a predictor of breast cancer characteristics and prognosis.
    Nucl Med Commun. 2021 Aug 19. pii: 00006231-900000000-97980.
    PubMed     Abstract available


  20. XUE XQ, Wang B, Yu WJ, Zhang FF, et al
    Relationship between total lesion glycolysis of primary lesions based on 18F-FDG PET/CT and lymph node metastasis in gastric adenocarcinoma: a cross-sectional preliminary study.
    Nucl Med Commun. 2021 Aug 17. pii: 00006231-900000000-97984.
    PubMed     Abstract available


  21. O' DOHERTY J, O' Doherty S, Robins EG, Reilhac A, et al
    Parametric mapping for 11C-metomidate PET-computed tomography imaging in the study of primary aldosteronism.
    Nucl Med Commun. 2021 Aug 17. pii: 00006231-900000000-97981.
    PubMed     Abstract available


  22. SHARMA A, Kumar S, Pandey AK, Arora G, et al
    Haralick texture features extracted from Ga-68 PSMA PET/CT to differentiate normal prostate from prostate cancer: a feasibility study.
    Nucl Med Commun. 2021 Aug 17. pii: 00006231-900000000-97987.
    PubMed     Abstract available


  23. KONG E, Choi J
    The new perspective of PET/CT for axillary nodal staging in early breast cancer patients according to ACOSOG Z0011 trial PET/CT axillary staging according to Z0011.
    Nucl Med Commun. 2021 Aug 9. pii: 00006231-900000000-97986.
    PubMed     Abstract available


  24. ORUC Z, Guzel Y, Ebinc S, Komek H, et al
    Efficacy of 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting response to second-generation androgen receptor axis-targeted therapy, and the prognosis in metastatic hormone-refractory prostate cancer patients.
    Nucl Med Commun. 2021 Aug 6. pii: 00006231-900000000-97990.
    PubMed     Abstract available


  25. DE SOUZA SPM, Tobar N, Frasson F, Perini EA, et al
    Head-to-head comparison between 68Ga-PSMA and 18F-FDG-PET/CT in lymphomas: a preliminary analysis.
    Nucl Med Commun. 2021 Aug 6. pii: 00006231-900000000-97989.
    PubMed     Abstract available


  26. KANEKO K, Baba S, Isoda T, Ishioka H, et al
    Compared to conventional PET/CT scanners, silicon-photomultiplier-based PET/CT scanners show higher arterial 18F-FDG uptake in whole-body 18F-FDG-PET/CT.
    Nucl Med Commun. 2021 Aug 3. pii: 00006231-900000000-97992.
    PubMed     Abstract available


  27. TAKAHASHI MES, Mosci C, Duarte GO, Pericole FV, et al
    Intensity of bone involvement: a quantitative 18F-FDG PET/CT evaluation for monitoring outcome of multiple myeloma.
    Nucl Med Commun. 2021 Aug 3. pii: 00006231-900000000-97991.
    PubMed     Abstract available


    July 2021
  28. YOUNG JD, Jauregui-Osoro M, Wong WL, Cooper MS, et al
    An overview of nuclear medicine research in the UK and the landscape for clinical adoption.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97998.
    PubMed     Abstract available


  29. NORIKANE T, Mitamura K, Yamamoto Y, Hatakeyama T, et al
    Correlation of 4'-[methyl-11C]-thiothymidine PET with Ki-67 immunohistochemistry separately in patients with newly diagnosed and recurrent gliomas.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97996.
    PubMed     Abstract available


  30. OKUDAN B, Coskun N, Seven B, Atalay MA, et al
    Assessment of volumetric parameters derived from 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence: an institutional experience.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97994.
    PubMed     Abstract available


  31. HUA J, Li L, Liu L, Liu Q, et al
    The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
    Nucl Med Commun. 2021 Jul 15. pii: 00006231-900000000-97999.
    PubMed     Abstract available


  32. DUONG MT, Chen YJ, Doot RK, Young AJ, et al
    Astrocyte activation imaging with 11C-acetate and amyloid PET in mild cognitive impairment due to Alzheimer pathology.
    Nucl Med Commun. 2021 Jul 5. pii: 00006231-900000000-98000.
    PubMed     Abstract available


  33. TEILER J, Akerlund B, Brismar H, Savitcheva I, et al
    Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection.
    Nucl Med Commun. 2021;42:719-724.
    PubMed     Abstract available


    June 2021
  34. KAPSORITAKIS N, Stathaki M, Bourogianni O, Tsaroucha A, et al
    Clinical impact of targeted single-photon emission computed tomography/computed tomography (SPECT/CT) bone scintigraphy on the assessment of bone metastasis in cancer patients.
    Nucl Med Commun. 2021 Jun 18. pii: 00006231-900000000-98001.
    PubMed     Abstract available


  35. NGUYEN TD, Lin D, Hernandez Pampaloni M
    False positive pharmacologic myocardial perfusion SPECT study in the setting of a left bundle branch block.
    Nucl Med Commun. 2021 Jun 7. pii: 00006231-900000000-98006.
    PubMed     Abstract available


  36. IGARASHI C, Yoshii Y, Tashima H, Iwao Y, et al
    Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.
    Nucl Med Commun. 2021 Jun 7. pii: 00006231-900000000-98005.
    PubMed     Abstract available


  37. COSKUN N, Okudan B, Uncu D, Kitapci MT, et al
    Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98011.
    PubMed     Abstract available


  38. DEV ID, Puranik AD, Purandare NC, Gupta T, et al
    Prognostic significance of 18F-FDG PET/CT parameters in IDH-1 wild-type GBM and correlation with molecular markers.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98010.
    PubMed     Abstract available


  39. AGRAWAL K, Swaroop S, Patro PSS, Tripathy SK, et al
    Comparison of bone SPECT/CT and MRI in detection of pain generator in ankle and foot pain: a retrospective diagnostic study.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98009.
    PubMed     Abstract available


  40. ABOUZIED MM, Alhinti N, AlMuhaideb A, Al Sugair AS, et al
    Extrahepatic metastases from hepatocellular carcinoma: multimodality image evaluation.
    Nucl Med Commun. 2021;42:583-591.
    PubMed     Abstract available


  41. ROSHDY E, ElNaggar M, Atta H, Kandeel A, et al
    Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma.
    Nucl Med Commun. 2021;42:625-632.
    PubMed     Abstract available


  42. TARTAGLIONE G, Foschi N, Recupero SM, Ieria FP, et al
    Advantages of gravity-assisted diuretic renogram: F + 10 (seated position) method.
    Nucl Med Commun. 2021;42:602-610.
    PubMed     Abstract available


  43. TAKALO R, Hytti H, Ihalainen H, Sohlberg A, et al
    Edge-preserving adaptive autoregressive model for Poisson noise reduction.
    Nucl Med Commun. 2021;42:707-710.
    PubMed     Abstract available


    May 2021
  44. ADIN ME, Uazeno H, Isufi E, Pang Y, et al
    Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University.
    Nucl Med Commun. 2021 May 26. pii: 00006231-900000000-98012.
    PubMed     Abstract available


  45. KURTH J, Kretzschmar J, Aladwan H, Heuschkel M, et al
    Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival.
    Nucl Med Commun. 2021 May 19. pii: 00006231-900000000-98017.
    PubMed     Abstract available


  46. SOYLUOGLU S, Korkmaz U, Ozdemir B, Ustun F, et al
    68Ga-PSMA-I&T-PET/CT interobserver and intraobserver agreement for prostate cancer: a lesion based and subregional comparison study among observers with different levels of experience.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98026.
    PubMed     Abstract available


  47. DIBBLE EH, Baird GL, Fahey FH, Hyun H, et al
    PET/computed tomography in inpatients: part 1, international survey.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98024.
    PubMed     Abstract available


  48. MESGUICH C, Hindie E, de Senneville BD, Tlili G, et al
    Improved 18-FDG PET/CT diagnosis of multiple myeloma diffuse disease by radiomics analysis.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98020.
    PubMed     Abstract available


  49. KARYAGAR S, Guven O, Karyagar SS, Arici S, et al
    Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?
    Nucl Med Commun. 2021 May 6. pii: 00006231-900000000-98030.
    PubMed     Abstract available


  50. LIU Y, Yao X, Wang C, Wang M, et al
    Peptide-based 68Ga-PET radiotracer for imaging CD133 expression in colorectal cancer.
    Nucl Med Commun. 2021 May 6. pii: 00006231-900000000-98029.
    PubMed     Abstract available



  51. Abstracts: British Nuclear Medicine Society Online Spring Meeting 18th-19th May 2021.
    Nucl Med Commun. 2021;42:575-581.
    PubMed    


    April 2021
  52. JIANG Y, Hou G, Huo L, Li F, et al
    18F-FDG PET/computed tomography scan in patients with suspicion of recurrent neuroendocrine carcinoma of the cervix.
    Nucl Med Commun. 2021 Apr 27. pii: 00006231-900000000-98032.
    PubMed     Abstract available


  53. KE L, Wu L, Yu J, Meng X, et al
    Feasibility of semiquantitative 18F-fluorodeoxyglucose PET/computed tomography in patients with advanced lung cancer for interim treatment evaluation of combining immunotherapy and chemotherapy.
    Nucl Med Commun. 2021 Apr 21. pii: 00006231-900000000-98033.
    PubMed     Abstract available


  54. KIM JY, Kim JY, Park SB, Kim C, et al
    A retrospective multicenter study of quantitative bone SPECT/CT to predict the surgical removal of the accessory navicular bone.
    Nucl Med Commun. 2021 Apr 16. pii: 00006231-900000000-98034.
    PubMed     Abstract available


  55. WATERSCHOOT R, D'Asseler Y, Goethals I
    Comparison of an in-house acquired brain F-18 FDG PET normal database with commercially available normal data.
    Nucl Med Commun. 2021 Apr 15. pii: 00006231-900000000-98035.
    PubMed     Abstract available


  56. RAUF MS, Khan ZA, Zahir MN, Al-Sweedan S, et al
    Comparison of 18F-labelled fluoro-2-deoxyglucose-PET with conventional computed tomography for staging and response assessment in paediatric and adult patients with nodular lymphocyte-predominant Hodgkin's lymphoma.
    Nucl Med Commun. 2021 Apr 9. pii: 00006231-900000000-98040.
    PubMed     Abstract available


  57. JALEEL J, Tripathi M, Baghel V, Arunraj ST, et al
    F-18 ML-104 tau PET imaging in mild cognitive impairment.
    Nucl Med Commun. 2021 Apr 9. pii: 00006231-900000000-98039.
    PubMed     Abstract available


  58. SIRAKRIENGKRAI K, Tepmongkol S, Keelawat S, Techavijit U, et al
    Clinical association of CXCR4 in primary tumor of papillary thyroid cancer and response to iodine-131 treatment.
    Nucl Med Commun. 2021;42:396-401.
    PubMed     Abstract available


  59. SHIN S, Kim K, Nam HY, Kim IJ, et al
    Sex difference in cerebral blood flow and cerebral glucose metabolism: an activation-likelihood estimation meta-analysis.
    Nucl Med Commun. 2021;42:410-415.
    PubMed     Abstract available


  60. COSTA IM, Pereira LR, Jessop M, Shawgi M, et al
    Lacrimal scintigraphy BNMS Guidelines.
    Nucl Med Commun. 2021;42:459-467.
    PubMed     Abstract available


  61. AYESA SL, Schembri GP
    Is 67gallium dead? A retrospective review of 67gallium imaging in a single tertiary referral centre.
    Nucl Med Commun. 2021;42:378-388.
    PubMed     Abstract available


  62. ALEXANDRE DJA, Carmo CCM, Romeiro LD, Gutfilen-Schlesinger G, et al
    99mTc-antitumor necrosis factor-alpha scintigraphy for the detection of inflammatory activity in rheumatoid arthritis.
    Nucl Med Commun. 2021;42:389-395.
    PubMed     Abstract available


    March 2021
  63. KUMAR N, Deo S, Bhoriwal S, Sharma A, et al
    Comparison of treatment response assessed by 18F-FDG PET/CT with the histopathological response using tumor regression grading on surgically resected specimen following neoadjuvant chemotherapy in squamous cell carcinoma of esophagus.
    Nucl Med Commun. 2021 Mar 30. pii: 00006231-900000000-98043.
    PubMed     Abstract available


  64. FALAY O, Selcukbiricik F, Tanju S, Erus S, et al
    The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic role.
    Nucl Med Commun. 2021 Mar 30. pii: 00006231-900000000-98042.
    PubMed     Abstract available


  65. REILLY C, Gemmell AJ, McLaughlin IM, Fleming R, et al
    Characterisation of 99mTc EDDA/HYNIC-TOC (Tektrotyd) physiological and neuroendocrine tumour uptake using SPECT/CT standardised uptake values: initial experience.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98060.
    PubMed     Abstract available


  66. D'ABADIE P, Walrand S, Hesse M, Annet L, et al
    Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98058.
    PubMed     Abstract available


  67. GARZA D, Kandathil A, Xi Y, Subramaniam RM, et al
    18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98057.
    PubMed     Abstract available


  68. SHIBUTANI T, Onoguchi M, Yoneyama H, Konishi T, et al
    Performance of SwiftScan planar and SPECT technology using low-energy high-resolution and sensitivity collimator compared with Siemens SPECT system.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98056.
    PubMed     Abstract available


  69. GAO YJ, Yang Z, Yu JY, Li N, et al
    Potential application value of PET/computed tomography in retroperitoneal leiomyosarcoma and a literature review.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98054.
    PubMed     Abstract available


  70. PARIDA GK, Panda RA, Agrawal K
    Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98053.
    PubMed     Abstract available


  71. JIANG Y, Hou G, Zhu Z, Huo L, et al
    18F-FDG PET/CT imaging features of patients with multicentric Castleman disease.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98052.
    PubMed     Abstract available


  72. CHHABRA A, Shukla J, Sharma U, Vatsa R, et al
    Re-188-tricarbonyl tamoxifen as a theranostic radiopharmaceutical for estrogen receptor expressing breast cancers: radiolabeling, characterization and in-vitro cytotoxic assessment.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98051.
    PubMed     Abstract available


  73. SINGH TP, Sharma A, Sharma A, Bakhshi S, et al
    Utility of 18F-FDG-PET/CT in management and prognostication of treatment naive late-stage soft tissue sarcomas.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98050.
    PubMed     Abstract available


  74. MAPELLI P, Callea M, Fallanca F, Castellano A, et al
    18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98049.
    PubMed     Abstract available


  75. QUARTUCCIO N, Salem A, Laudicella R, Spataro A, et al
    The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98048.
    PubMed     Abstract available


  76. ORITA E, Becker D, Mueller M, Hefti M, et al
    FDG-PET/CT: novel method for viability assessment of livers perfused ex vivo.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98047.
    PubMed     Abstract available


  77. BARATTO L, Wu F, Minamimoto R, Hatami N, et al
    Correlation of 18-fluorodeoxyglucose PET/computed tomography parameters and clinical features to predict outcome for diffuse large B-cell lymphoma.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98046.
    PubMed     Abstract available


  78. BAIOMY A, Schellingerhout D, Chapin BF, Weinberg JS, et al
    Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.
    Nucl Med Commun. 2021 Mar 12. pii: 00006231-900000000-98061.
    PubMed     Abstract available


  79. TEICHNER EM, You JC, Hriso C, Wintering NA, et al
    Alterations in cerebral glucose metabolism as measured by 18F-fluorodeoxyglucose-PET in patients with persistent postconcussion syndrome.
    Nucl Med Commun. 2021 Mar 3. pii: 00006231-900000000-98064.
    PubMed     Abstract available


  80. VOUILLARMET J, Tordo J, Moret M, Michon P, et al
    99mTc-white blood cell SPECT/CT to assess diabetic foot osteomyelitis remission: contribution of semi-quantitative scoring system.
    Nucl Med Commun. 2021 Mar 3. pii: 00006231-900000000-98063.
    PubMed     Abstract available


  81. JHA AK, Mithun S, Rangarajan V, Wee L, et al
    Emerging role of artificial intelligence in nuclear medicine.
    Nucl Med Commun. 2021 Mar 1. pii: 00006231-900000000-98069.
    PubMed     Abstract available


  82. LIU H, Dang H, Wang R, Yao S, et al
    Analysis of the F-18 FDG PET/CT features of pulmonary sclerosing pneumocytoma.
    Nucl Med Commun. 2021 Mar 1. pii: 00006231-900000000-98068.
    PubMed     Abstract available


  83. AUJAY G, Debordeaux F, Blanc JF, Lapuyade B, et al
    18F-choline PET-computed tomography for the prediction of early treatment responses to transarterial radioembolization in patients with hepatocellular carcinoma.
    Nucl Med Commun. 2021 Mar 1. pii: 00006231-900000000-98067.
    PubMed     Abstract available


  84. AL-IBRAHEEM A, Abuhijla F, Salah S, Shahait M, et al
    The influence of 68Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapy.
    Nucl Med Commun. 2021 Mar 1. pii: 00006231-900000000-98066.
    PubMed     Abstract available


  85. MIYAJI N, Miwa K, Motegi K, Yamashita K, et al
    Patient arm position during quantitative bone single-photon emission computed tomography/computed tomography acquisition can affect image quality and quantitative accuracy: a phantom study.
    Nucl Med Commun. 2021;42:267-275.
    PubMed     Abstract available


  86. PURANIK AD, Rangarajan V, Gosavi A, Shetty N, et al
    Prognostic value of imaging-based parameters in patients with intermediate-stage hepatocellular carcinoma undergoing transarterial radioembolization.
    Nucl Med Commun. 2021;42:337-344.
    PubMed     Abstract available


  87. HUANG YC, Hsu CC, Wu YC, Chen HJ, et al
    Effect of fasting duration on myocardial fluorodeoxyglucose uptake in diabetic and nondiabetic patients.
    Nucl Med Commun. 2021;42:300-305.
    PubMed     Abstract available


  88. TUTINO F, Puccini G, Linguanti F, Puccini B, et al
    Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: interobserver agreement and reproducibility across software platforms.
    Nucl Med Commun. 2021;42:284-291.
    PubMed     Abstract available


  89. LIU B, Yu W, Wang J, Shao X, et al
    Incremental value of regional wall motion abnormalities for detecting obstructive coronary artery disease by rest-only electrocardiogram-gated single-photon emission computerized tomography myocardial perfusion imaging in suspected coronary artery dis
    Nucl Med Commun. 2021;42:276-283.
    PubMed     Abstract available


    February 2021
  90. CHOI EK, Oh JK, Seo YY, Im JJ, et al
    Prognostic value of pretreatment F-18 fluorodeoxyglucose PET/CT in colorectal cancer with unresectable metastasis.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98080.
    PubMed     Abstract available


  91. AGRAWAL K, Padhy BM, Meher BR, Mohanty RR, et al
    Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98078.
    PubMed     Abstract available


  92. OZMEN O, Tatci E, Demiroz SM, Tazeler Z, et al
    Is 18F-FDG PET/CT capable of differential diagnosis from tuberculous pleurisy from malignant mesothelioma?
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98075.
    PubMed     Abstract available


  93. YOO SW, Kim DY, Pyo A, Jeon S, et al
    Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98074.
    PubMed     Abstract available


  94. LIU ZF, Ye QN, Yang J, Yang M, et al
    Preclinical evaluation of [68Ga]Ga-MALAT-1-antisense oligonucleotides for specific PET imaging of MALAT-1 expressing tumours.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98072.
    PubMed     Abstract available


  95. WONG JM, Puri T, Siddique MM, Frost ML, et al
    Comparison of ordered-subset expectation maximization and filtered back projection reconstruction based on quantitative outcome from dynamic [18F]NaF PET images.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98071.
    PubMed     Abstract available


  96. KIM JS, Park CR, Yoon SH, Lee JA, et al
    Improvement of image quality using amplitude-based respiratory gating in PET-computed tomography scanning.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98070.
    PubMed     Abstract available


  97. SHARMA A, Phulia A, Sethi RS
    PET/computed tomography enterography.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98088.
    PubMed     Abstract available


  98. MOHAMADIEN NRA, Sayed MHM
    Correlation between semiquantitative and volumetric 18F-FDG PET/computed tomography parameters and Ki-67 expression in breast cancer.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98087.
    PubMed     Abstract available


  99. ADNAN A, Basu S
    Concept proposal for a six-tier integrated dual tracer PET-CT (68Ga-PSMA and FDG) image scoring system ('Pro-PET' score) and examining its potential implications in metastatic castration-resistant prostate carcinoma theranostics and prognosis.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98085.
    PubMed     Abstract available


  100. AKSU A, Karahan Sen NP, Tuna EB, Aslan G, et al
    Evaluation of 68Ga-PSMA PET/CT with volumetric parameters for staging of prostate cancer patients.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98084.
    PubMed     Abstract available


  101. MATHEW B, Purandare NC, Pramesh CS, Karimundackal G, et al
    Improving accuracy of 18F-fluorodeoxyglucose PET computed tomography to diagnose nodal involvement in non-small cell lung cancer: utility of using various predictive models.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98083.
    PubMed     Abstract available


  102. WAKFIE-CORIEH CG, Rodriguez Rey C, Ortega Candil A, Ferrando-Castagnetto F, et al
    Clinical relevance of incidental focal breast uptake on fluorine-18 fluorodeoxyglucose PET/computed tomography studies: an experience in a high-load center of Spain.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98082.
    PubMed     Abstract available


  103. QUARTUCCIO N, Panareo S, Urso L, Sturiale L, et al
    Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement.
    Nucl Med Commun. 2021;42:198-204.
    PubMed     Abstract available


  104. JIANG W, Liu Y, He Z, Zhou Y, et al
    Prognostic value of left ventricular mechanical dyssynchrony in hypertrophic cardiomyopathy patients with low risk of sudden cardiac death.
    Nucl Med Commun. 2021;42:182-189.
    PubMed     Abstract available


  105. BESTETTI A, Cuko B, Gasparini M, De Servi S, et al
    Direct correlation between ischemic burden induced by dipyridamole and stress peak filling rate: a gated perfusion single-photon emission computed tomography study.
    Nucl Med Commun. 2021;42:173-181.
    PubMed     Abstract available


  106. HUANG MS, Chen TW, Liu YS, Wang YS, et al
    The impact of permanent pacemaker implantation on thallium myocardial perfusion examination detecting ischemic heart disease.
    Nucl Med Commun. 2021;42:190-197.
    PubMed     Abstract available


  107. DE NIJS R, Sijtsema ND, Kruis MF, Jensen CV, et al
    Comparison of 81mKrypton and 99mTc-Technegas for ventilation single-photon emission computed tomography in severe chronic obstructive pulmonary disease.
    Nucl Med Commun. 2021;42:160-168.
    PubMed     Abstract available


    January 2021
  108. KOHLENBERG JD, Panda A, Johnson GB, Castro MR, et al
    Radiologic and clinicopathologic characteristics of thyroid nodules with focal 68Ga-DOTATATE PET activity.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98093.
    PubMed     Abstract available


  109. THAKAR A, Sakthivel P, Arunraj ST, Bhalla AS, et al
    Clinical utility of Ga68 DOTANOC PET/CT imaging in juvenile nasal angiofibroma and the PARIS protocol: a preliminary report.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98092.
    PubMed     Abstract available


  110. MINGELS C, Sachpekidis C, Bohn KP, Hunermund JN, et al
    The influence of colour scale in lesion detection and patient-based sensitivity in [68Ga]Ga-PSMA-PET/CT.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98091.
    PubMed     Abstract available


  111. CHEN B, Zhang H, Liu D, Wang X, et al
    Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98090.
    PubMed     Abstract available


  112. SONG Y, Wang PY, Zheng Y, Liu C, et al
    Expression of TIGAR and its correlation with clinicopathology, prognosis, and 18F-FDG PET/CT parameters in patients with resectable pancreatic ductal adenocarcinoma.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98089.
    PubMed     Abstract available


  113. OZGUVEN S, Ones T, Bozkurtlar E, Yanartas M, et al
    Chronic thromboembolic pulmonary hypertension: evaluation of V/Q SPECT/CT and V/Q Quotient SPECT findings with postoperative results of pulmonary endarterectomy.
    Nucl Med Commun. 2021 Jan 11. pii: 00006231-900000000-98094.
    PubMed     Abstract available


  114. MOHD ROHANI MF, Zanial AZ, Suppiah S, Phay Phay K, et al
    Bone single-photon emission computed tomography/computed tomography in cancer care in the past decade: a systematic review and meta-analysis as well as recommendations for further work.
    Nucl Med Commun. 2021;42:9-20.
    PubMed     Abstract available


  115. SCHENKE SA, Klett R, Wagner PR, Mott S, et al
    Characteristics of different histological subtypes of thyroid nodules classified with 99mTc-methoxy-isobutyl-isonitrile imaging and Thyroid Imaging Reporting And Data System.
    Nucl Med Commun. 2021;42:73-80.
    PubMed     Abstract available


  116. ZHANG Y, Li B, Yu H, Song J, et al
    The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.
    Nucl Med Commun. 2021;42:63-67.
    PubMed     Abstract available


  117. HEIMANN I, Kuttenberger J, Della Chiesa A, Bhure U, et al
    Monitoring jaw osteomyelitis therapy with single-photon emission computed tomography/computed tomography.
    Nucl Med Commun. 2021;42:51-57.
    PubMed     Abstract available


  118. SHINTO AS, Karuppusamy KK, Kurup RER, Pandiyan A, et al
    Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma.
    Nucl Med Commun. 2021;42:43-50.
    PubMed     Abstract available


    December 2020
  119. MALIHA PG, Singerman J, Abikhzer G, Probst S, et al
    Physiologic prostate-specific membrane antigen-targeted 18F-DCFPyL uptake in the epididymis head newly appreciated on digital PET/CT.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  120. SINGH B, Sharma S, Bansal P, Hooda M, et al
    Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  121. DIZDAREVIC S, Abdulla M, Sewedy T, Weston C, et al
    Impact of COVID-19 on nuclear medicine in the UK.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  122. BATTAL H, Ozer AY
    Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  123. MOSTAFA R, Abdelhafez YG, Abougabal M, Nardo L, et al
    Two-bed SPECT/CT versus planar bone scintigraphy: prospective comparison of reproducibility and diagnostic performance.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  124. BORJA AJ, Hancin EC, Zhang V, Koa B, et al
    Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001349.
    PubMed     Abstract available


  125. HOEKSTRA RJ, Beulens A, Vrijhof EHJEJ, Wyndaele DNJ, et al
    Diagnostic accuracy of 18F-fluciclovine PET/CT in primary lymph node staging of prostate cancer.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001352.
    PubMed     Abstract available


  126. JIN J, Wu K, Li X, Yu Y, et al
    Relationship between tumor heterogeneity and volume in cervical cancer: Evidence from integrated fluorodeoxyglucose 18 PET/MR texture analysis.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001354.
    PubMed     Abstract available


  127. WU D, Plyku D, Kulkarni K, Garcia C, et al
    The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001330.
    PubMed     Abstract available


  128. WONG WL, Ross P, Peters K, Frenz M, et al
    The COVID-19 pandemic: impact on NHS England PET-CT services and lessons learnt.
    Nucl Med Commun. 2020 Dec 10. doi: 10.1097/MNM.0000000000001346.
    PubMed     Abstract available


  129. AKDENIZ N, Komek H, Kucukoner M, Kaplan MA, et al
    The role of basal 18F-FDG PET/CT maximum standard uptake value and maximum standard uptake change in predicting pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
    Nucl Med Commun. 2020 Dec 10. doi: 10.1097/MNM.0000000000001332.
    PubMed     Abstract available


  130. TUSTUMI F, Duarte PS, Albenda DG, Takeda FR, et al
    Prognostic value of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters measured in the primary tumor and suspicious lymph nodes before neoadjuvant therapy in patients with esophageal carcinoma.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001347.
    PubMed     Abstract available


  131. WAN QC, Li JF, Tang LL, Lv J, et al
    Comparing the diagnostic accuracy of 4D CT and 99mTc-MIBI SPECT/CT for localizing hyperfunctioning parathyroid glands: a systematic review and meta-analysis.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001331.
    PubMed     Abstract available


  132. FUENTES-OCAMPO F, Lopez-Mora DA, Flotats A, Camacho V, et al
    Digital versus analog PET/CT in patients with known or suspected liver metastases.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001341.
    PubMed     Abstract available


  133. RODRIGUEZ TAROCO MG, Cuna EG, Pages C, Schelotto M, et al
    Prognostic value of imaging markers from 18FDG-PET/CT in paediatric patients with Hodgkin lymphoma.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001337.
    PubMed     Abstract available


  134. AYUBCHA C, Raynor WY, Borja AJ, Seraj SM, et al
    Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001344.
    PubMed     Abstract available


  135. JAIN TK, Singh G, Goyal S, Malhotra H, et al
    Is F-18 FDG PET/computed tomography a useful tool to restage the patients with tongue carcinoma?
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001336.
    PubMed     Abstract available


  136. ZHANG LZ, Li S, Jiang Y, Qiu ZL, et al
    Clinical usefulness of single photon emission tomography/computed tomography with stress analysis in early diagnoses of stem instability of noncemented hip arthroplasty.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001323.
    PubMed     Abstract available


    November 2020
  137. PRAKASH S, Kumar R, Vinjamuri S
    What role does 18F-fluorodeoxyglucose PET-computed tomography have in the current pandemic and beyond?
    Nucl Med Commun. 2020 Nov 27. doi: 10.1097/MNM.0000000000001320.
    PubMed    


  138. FLAUS A, Nevesny S, Guy JB, Sotton S, et al
    Positron emission tomography for radiotherapy planning in head and neck cancer: What impact?
    Nucl Med Commun. 2020 Nov 27. doi: 10.1097/MNM.0000000000001329.
    PubMed     Abstract available


  139. JU H, Paycha F
    Osteoblastic and hyperostotic craniofacial lesion detected by 99mTc-labeled methylene diphosphonate bone scintigraphy and single-photon emission computed tomography/computed tomography: a pictorial essay.
    Nucl Med Commun. 2020 Nov 5. doi: 10.1097/MNM.0000000000001318.
    PubMed     Abstract available


  140. PANDA A, Hintermeister HA, Hunt CH, Kendi AT, et al
    Whole-body 18-F-FDG-PET in patients with leptomeningeal disease and correlation with MRI.
    Nucl Med Commun. 2020 Nov 5. doi: 10.1097/MNM.0000000000001317.
    PubMed     Abstract available


  141. KANDEEL A, Saied M, Aldaly M, Darwish H, et al
    Impact of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography on the initial staging and changing the management intent in head and neck squamous cell carcinoma.
    Nucl Med Commun. 2020 Nov 5. doi: 10.1097/MNM.0000000000001316.
    PubMed     Abstract available


  142. LOCOCO F, Sassorossi C, Chiappetta M, Cesario A, et al
    Correlation between 18F-FDG PET/computer tomography findings and histology in thymic epithelial tumors: current evidences and clinical implications.
    Nucl Med Commun. 2020;41:1221-1222.
    PubMed    


    October 2020
  143. HANSEN SL, Bebbington NA
    Estimation of CARE Dose 4D quality reference mAs conversion factors for child to adult reference patient in child protocols on Siemens Symbia SPECT-CT systems.
    Nucl Med Commun. 2020 Oct 16. doi: 10.1097/MNM.0000000000001312.
    PubMed     Abstract available


  144. ANDERSEN JD, Zacho HD, Petersen LJ
    The frequency and malignancy rate of incidental focal breast lesions identified by 18F-fluorodeoxyglucose positron emission tomography.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001309.
    PubMed     Abstract available


  145. ISHIWATA Y, Kaneta T, Nawata S, Iizuka H, et al
    Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-fluorodeoxyglucose PET/computed tomography images of largest metastatic lymph node.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001310.
    PubMed     Abstract available


  146. LEE HJ, Lim HS, Ki SY, Park HM, et al
    18F-fluorodeoxyglucose uptake on PET/computed tomography in association with androgen receptor expression and other clinicopathologic factors in surgically resected triple-negative breast cancer.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001300.
    PubMed     Abstract available


  147. ZHANG L, Chen J, Xu C, Zhang Y, et al
    The value of 4D fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of lung lesions.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001289.
    PubMed     Abstract available


  148. UGUR A, Yaylali O, Yuksel D
    Examination of metallic impurities of 68Ge/68Ga generators used for radioactive labeling of peptides in clinical PET applications.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001307.
    PubMed     Abstract available


  149. DINET J, Tonnelet D, Le Cloirec J, Becker S, et al
    Red cell volume measurement: using technetium as a replacement for chromium.
    Nucl Med Commun. 2020;41:1106-1107.
    PubMed    


  150. MAPELLI P, Ironi G, Bergamini A, Mangili G, et al
    Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer.
    Nucl Med Commun. 2020;41:1073-1080.
    PubMed     Abstract available



  151. British Nuclear Medicine Society Autumn Meeting 2020.
    Nucl Med Commun. 2020;41:1109-1110.
    PubMed    


    September 2020
  152. KATAL S, Amini H, Gholamrezanezhad A
    PET in the diagnostic management of infectious/inflammatory pulmonary pathologies: a revisit in the era of COVID-19.
    Nucl Med Commun. 2020 Sep 24. doi: 10.1097/MNM.0000000000001299.
    PubMed    


  153. TASDEMIR B, Guzel Y, Komek H, Can C, et al
    Evaluation of dual time-point fluorodeoxyglucose PET/computed tomography imaging in gastric cancer.
    Nucl Med Commun. 2020 Sep 21. doi: 10.1097/MNM.0000000000001290.
    PubMed     Abstract available


  154. LIU Y, Wang G, Yu H, Wu Y, et al
    Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
    Nucl Med Commun. 2020 Sep 15. doi: 10.1097/MNM.0000000000001285.
    PubMed     Abstract available


  155. SASIDHARAN A, Murthy V, Natarajan A, Agarwal A, et al
    Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI.
    Nucl Med Commun. 2020 Sep 15. doi: 10.1097/MNM.0000000000001283.
    PubMed     Abstract available


  156. KIM K, Kim SJ
    Diagnostic performance of F-18 fluorodeoxyglucose PET/computed tomography for diagnosis of polymyalgia rheumatica: a meta-analysis.
    Nucl Med Commun. 2020 Sep 15. doi: 10.1097/MNM.0000000000001292.
    PubMed     Abstract available


  157. MAYES CD
    Safe practice ventilation technique in lung scanning for pulmonary embolism.
    Nucl Med Commun. 2020 Sep 15. doi: 10.1097/MNM.0000000000001278.
    PubMed     Abstract available


  158. SAGHEB S, Metser U, Razaz S, Menezes R, et al
    Preliminary evaluation of 18F-FDG-PET/MRI for differentiation of serous from nonserous pancreatic cystic neoplasms: a pilot study.
    Nucl Med Commun. 2020 Sep 5. doi: 10.1097/MNM.0000000000001277.
    PubMed     Abstract available


  159. LUO Y, Zhang Y, Pan Q, Zhang Y, et al
    18F-FDG PET/computed tomography may predict the outcome of newly diagnosed indolent non-Hodgkin lymphoma in patients managed with initial 'watch-and-wait' approach.
    Nucl Med Commun. 2020 Sep 5. doi: 10.1097/MNM.0000000000001279.
    PubMed     Abstract available


  160. VADALA M, Cistaro A, Quartuccio N, Calcagni ML, et al
    18F-FDG-PET brain imaging may highlight brain metabolic alterations in dysautonomic syndrome after human papilloma virus vaccination.
    Nucl Med Commun. 2020 Sep 3. doi: 10.1097/MNM.0000000000001280.
    PubMed     Abstract available


  161. VOO S, Dizdarevic S
    Single photon emission computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines?
    Nucl Med Commun. 2020;41:991-993.
    PubMed    


  162. SANGHERA B, Fenwick A, Lowe G, Sullivan K, et al
    Radionuclide calibrator intercomparison study of clinical PET centres in England to a single traceable 68Ge syringe source.
    Nucl Med Commun. 2020;41:965-976.
    PubMed     Abstract available


  163. PANDE SS, Purandare N, Puranik A, Shah S, et al
    Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resection.
    Nucl Med Commun. 2020;41:959-964.
    PubMed     Abstract available


  164. ZHONG X, Diao W, Zhao C, Jia Z, et al
    Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients.
    Nucl Med Commun. 2020;41:950-958.
    PubMed     Abstract available


  165. XIAO J, Wang D, Guo B, Wang L, et al
    Observer agreement and accuracy of 18F-sodium fluoride PET/computed tomography in the diagnosis of skull-base bone invasion and osseous metastases in newly diagnosed nasopharyngeal carcinoma.
    Nucl Med Commun. 2020;41:942-949.
    PubMed     Abstract available


  166. XIAO J, Hu B, Cheng D, Shi H, et al
    Features of IgG4-related lung disease on 18F-FDG PET/computed tomography imaging.
    Nucl Med Commun. 2020;41:933-941.
    PubMed     Abstract available


  167. YADAV D, Shamim SA, Rastogi S, Upadhyay DMR, et al
    Role of 18F-FDG PET/computed tomography in prognostication and management of malignant peripheral nerve sheath tumors.
    Nucl Med Commun. 2020;41:924-932.
    PubMed     Abstract available


  168. GRUT H, Stern NM, Dueland S, Labori KJ, et al
    Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases.
    Nucl Med Commun. 2020;41:916-923.
    PubMed     Abstract available


  169. TEYATEETI A, Khan B, Teyateeti A, Chen B, et al
    Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level
    Nucl Med Commun. 2020;41:906-915.
    PubMed     Abstract available


  170. MAPELLI P, Partelli S, Salgarello M, Doraku J, et al
    Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment.
    Nucl Med Commun. 2020;41:896-905.
    PubMed     Abstract available


  171. PAWAR SU, Ravat SH, Muzumdar DP, Sankhe SS, et al
    Does Tc-99m ECD ictal brain SPECT have incremental value in localization of epileptogenic zone and predicting postoperative seizure freedom in cases with discordant video electroencephalogram and MRI findings?
    Nucl Med Commun. 2020;41:858-870.
    PubMed     Abstract available


  172. RANI N, Singh B, Kumar N, Singh P, et al
    The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices.
    Nucl Med Commun. 2020;41:848-857.
    PubMed     Abstract available


  173. SHIRI I, Abdollahi H, Atashzar MR, Rahmim A, et al
    A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease.
    Nucl Med Commun. 2020;41:837-840.
    PubMed    


    August 2020
  174. HENRIKSEN OM, Holm S, Marner L, Law I, et al
    Effect of blood glucose and body weight on image quality in brain [18F]FDG PET imaging.
    Nucl Med Commun. 2020 Aug 27. doi: 10.1097/MNM.0000000000001281.
    PubMed     Abstract available


  175. SATO S, Fujiwara S, Miyoshi K, Chida K, et al
    Improvement in gait function after carotid endarterectomy is associated with postoperative recovery in perfusion and neurotransmitter receptor function in the motor-related cerebral cortex: a 123I-iomazenil SPECT study.
    Nucl Med Commun. 2020 Aug 18. doi: 10.1097/MNM.0000000000001275.
    PubMed     Abstract available


  176. LIAO X, Cui Y, Chen X, Di L, et al
    Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients.
    Nucl Med Commun. 2020 Aug 18. doi: 10.1097/MNM.0000000000001274.
    PubMed     Abstract available


  177. TELO S, Fanti S, Nanni C, Lambertini A, et al
    Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL.
    Nucl Med Commun. 2020 Aug 13. doi: 10.1097/MNM.0000000000001266.
    PubMed     Abstract available


  178. GABRIELSON S, Tsai JA, Celebioglu F, Nilsson M, et al
    Preoperative detection of sentinel lymph nodes with hybrid SPECT/computed tomography imaging may improve the accuracy of sentinel lymph node biopsies in patients with early stages of cancer of the oesophagus or gastro-oesophageal junction.
    Nucl Med Commun. 2020 Aug 11. doi: 10.1097/MNM.0000000000001273.
    PubMed     Abstract available


  179. AYDOS U, Tahtaci G, Ozgur Akdemir U, Ozet A, et al
    18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
    Nucl Med Commun. 2020 Aug 10. doi: 10.1097/MNM.0000000000001272.
    PubMed     Abstract available


  180. YAMANAKA M, Shinya T, Otomi Y, Kubo M, et al
    Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study.
    Nucl Med Commun. 2020 Aug 10. doi: 10.1097/MNM.0000000000001271.
    PubMed     Abstract available


  181. RAJU S, Sharma A, Patel C, Sahoo R, et al
    Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
    Nucl Med Commun. 2020 Aug 10. doi: 10.1097/MNM.0000000000001268.
    PubMed     Abstract available


  182. KASALAK O, Yakar D, Dierckx RAJO, Kwee TC, et al
    Patient safety in nuclear medicine: identification of key strategic areas for vigilance and improvement.
    Nucl Med Commun. 2020 Aug 4. doi: 10.1097/MNM.0000000000001262.
    PubMed     Abstract available


    July 2020
  183. DE MOOIJ CM, Sunen I, Mitea C, Lalji UC, et al
    Diagnostic performance of PET/computed tomography versus PET/MRI and diffusion-weighted imaging in the N- and M-staging of breast cancer patients.
    Nucl Med Commun. 2020 Jul 28. doi: 10.1097/MNM.0000000000001254.
    PubMed     Abstract available


  184. MOSCI C, Pericole FV, Oliveira GB, Delamain MT, et al
    99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma.
    Nucl Med Commun. 2020 Jul 23. doi: 10.1097/MNM.0000000000001259.
    PubMed     Abstract available


  185. SINGH D, Shukla J, Walia R, Vatsa R, et al
    Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001251.
    PubMed     Abstract available


  186. MALIHA PG, Singerman J, Probst S
    Weight loss as primary indication for FDG-PET/CT.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001250.
    PubMed     Abstract available


  187. YOU H, Kandathil A, Beg M, De Blanche L, et al
    Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001255.
    PubMed     Abstract available


  188. FILIPPI L, Fontana A, Spinelli GP, Rossi L, et al
    Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001260.
    PubMed     Abstract available


  189. MENON BK, Kalshetty A, Bhattacharjee A, Basu S, et al
    Standardized uptake values and ratios on 68Ga-DOTATATE PET-computed tomography for normal organs and malignant lesions and their correlation with Krenning score in patients with metastatic neuroendocrine tumors.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001253.
    PubMed     Abstract available


  190. PURANDARE NC, Puranik A, Agrawal A, Shah S, et al
    Does 68Ga-DOTA-NOC-PET/CT impact staging and therapeutic decision making in pulmonary carcinoid tumors?
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001248.
    PubMed     Abstract available


  191. COCKBURN N, Corsaut J, Kovacs MS, St Lawrence K, et al
    Validation protocol for current good manufacturing practices production of [15O]water for hybrid PET/MR studies.
    Nucl Med Commun. 2020 Jul 14. doi: 10.1097/MNM.0000000000001249.
    PubMed     Abstract available


  192. LABEUR TA, Cieslak KP, Van Gulik TM, Takkenberg RB, et al
    The utility of 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT/CT for selective internal radiation therapy in hepatocellular carcinoma.
    Nucl Med Commun. 2020 Jul 3. doi: 10.1097/MNM.0000000000001224.
    PubMed     Abstract available


  193. VOO S, Dizdarevic S
    Single photon emission computed tomography-computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines?
    Nucl Med Commun. 2020 Jul 3. doi: 10.1097/MNM.0000000000001246.
    PubMed    


  194. XIAO J, Wang D, Guo B, Wang L, et al
    Observer agreement and accuracy of 18F-sodium fluoride PET/computed tomography in the diagnosis of skull-base bone invasion and osseous metastases in newly diagnosed nasopharyngeal carcinoma.
    Nucl Med Commun. 2020 Jul 3. doi: 10.1097/MNM.0000000000001243.
    PubMed     Abstract available


  195. HANSROD S, James G, Notghi A, Croasdale J, et al
    Gastric emptying: methodology and normal ranges for two commonly used meals in the UK.
    Nucl Med Commun. 2020;41:636-650.
    PubMed     Abstract available


  196. FENG L, Zhang Z, Malam Djibo I, Chen S, et al
    The efficacy of single-photon emission computed tomography in identifying dystonic muscles in cervical dystonia.
    Nucl Med Commun. 2020;41:651-658.
    PubMed     Abstract available


  197. GUNER LA, Unal K, Vardareli E, Kaya E, et al
    Physiological fluorodeoxyglucose uptake of spinal cord in adults.
    Nucl Med Commun. 2020;41:659-665.
    PubMed     Abstract available


  198. FUJIWARA K, Akiba H, Tsuji AB, Sudo H, et al
    64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time.
    Nucl Med Commun. 2020;41:688-695.
    PubMed     Abstract available


  199. JOHNSON S, Gulliver N, King S, Meadows A, et al
    Technical note on the administration of intravenous contrast media in hybrid imaging.
    Nucl Med Commun. 2020;41:706-713.
    PubMed     Abstract available


    June 2020
  200. SANGHERA B, Fenwick A, Lowe G, Sullivan K, et al
    Radionuclide calibrator intercomparison study of clinical PET centres in England to a single traceable 68Ge syringe source.
    Nucl Med Commun. 2020 Jun 23. doi: 10.1097/MNM.0000000000001241.
    PubMed     Abstract available


  201. YADAV D, Shamim SA, Rastogi S, Upadhyay DMR, et al
    Role of 18F-FDG PET/computed tomography in prognostication and management of malignant peripheral nerve sheath tumors.
    Nucl Med Commun. 2020 Jun 23. doi: 10.1097/MNM.0000000000001237.
    PubMed     Abstract available


  202. ZHONG X, Diao W, Zhao C, Jia Z, et al
    Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients.
    Nucl Med Commun. 2020 Jun 23. doi: 10.1097/MNM.0000000000001242.
    PubMed     Abstract available


  203. PAWAR SU, Ravat SH, Muzumdar DP, Sankhe SS, et al
    Does Tc-99m ECD ictal brain SPECT have incremental value in localization of epileptogenic zone and predicting postoperative seizure freedom in cases with discordant video electroencephalogram and MRI findings?
    Nucl Med Commun. 2020 Jun 23. doi: 10.1097/MNM.0000000000001240.
    PubMed     Abstract available


  204. MAPELLI P, Partelli S, Salgarello M, Doraku J, et al
    Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment.
    Nucl Med Commun. 2020 Jun 18. doi: 10.1097/MNM.0000000000001236.
    PubMed     Abstract available


  205. PANDE SS, Purandare N, Puranik A, Shah S, et al
    Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resection.
    Nucl Med Commun. 2020 Jun 18. doi: 10.1097/MNM.0000000000001229.
    PubMed     Abstract available


  206. RANI N, Singh B, Kumar N, Singh P, et al
    The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices.
    Nucl Med Commun. 2020 Jun 18. doi: 10.1097/MNM.0000000000001230.
    PubMed     Abstract available


  207. GRUT H, Stern NM, Dueland S, Labori KJ, et al
    Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases.
    Nucl Med Commun. 2020 Jun 18. doi: 10.1097/MNM.0000000000001235.
    PubMed     Abstract available


  208. XIAO J, Hu B, Cheng D, Shi H, et al
    Features of IgG4-related lung disease on 18F-FDG PET/computed tomography imaging.
    Nucl Med Commun. 2020 Jun 17. doi: 10.1097/MNM.0000000000001238.
    PubMed     Abstract available


  209. KITAJIMA K, Maruyama M, Minami T, Yokoi T, et al
    Comparison of modified Response Evaluation Criteria in Solid Tumors, European Organization for Research and Treatment of Cancer criteria, and PET Response Criteria in Solid Tumors for evaluation of tumor response to chemotherapy and prognosis predicti
    Nucl Med Commun. 2020 Jun 8. doi: 10.1097/MNM.0000000000001223.
    PubMed     Abstract available


  210. TEYATEETI A, Khan B, Teyateeti A, Chen B, et al
    Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level
    Nucl Med Commun. 2020 Jun 8. doi: 10.1097/MNM.0000000000001228.
    PubMed     Abstract available


  211. ONNER H, Abdulrezzak U, Tutus A
    Could the skewness and kurtosis texture parameters of lesions obtained from pretreatment Ga-68 DOTA-TATE PET/CT images predict receptor radionuclide therapy response in patients with gastroenteropancreatic neuroendocrine tumors?
    Nucl Med Commun. 2020 Jun 8. doi: 10.1097/MNM.0000000000001231.
    PubMed     Abstract available


  212. CASTANHEIRA J, Mascarenhas Gaivao A, Mairos Teixeira S, Pereira PJ, et al
    Asymptomatic COVID-19 positive patient suspected on FDG-PET/CT.
    Nucl Med Commun. 2020;41:598-599.
    PubMed    


  213. VOO S, Neriman D, Henry M, Kayani I, et al
    Perfusion-ventilation imaging in an era of COVID-19.
    Nucl Med Commun. 2020;41:597-598.
    PubMed    


  214. SYED A, Levart D, Vadrucci M, Gibson V, et al
    Absence of hepatic activity in lymphoscintigraphy performed with Tc-99m-Nanoscan.
    Nucl Med Commun. 2020;41:505-509.
    PubMed     Abstract available


  215. DUMONT SM, Costa HS, Chaves AT, Nunes MDCP, et al
    Radionuclide esophageal transit scintigraphy in chronic indeterminate and cardiac forms of Chagas disease.
    Nucl Med Commun. 2020;41:510-516.
    PubMed     Abstract available


    May 2020
  216. MANABE O, Klein R, Katoh C, Magota K, et al
    Validation of regional myocardial blood flow quantification using three-dimensional PET with rubidium-82: repeatability and comparison with two-dimensional PET data acquisition.
    Nucl Med Commun. 2020 May 25. doi: 10.1097/MNM.0000000000001218.
    PubMed     Abstract available


  217. AYDOS U, Arhan E, Akdemir UO, Akbas Y, et al
    Utility of brain fluorodeoxyglucose PET in children with possible autoimmune encephalitis.
    Nucl Med Commun. 2020 May 25. doi: 10.1097/MNM.0000000000001222.
    PubMed     Abstract available


  218. DEMIRCI E, Akyel R, Caner B, Alan-Selcuk N, et al
    Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.
    Nucl Med Commun. 2020 May 21. doi: 10.1097/MNM.0000000000001219.
    PubMed     Abstract available


  219. BROOS WAM, Wondergem M, van der Zant FM, Schaper NC, et al
    Dynamic 18F-fluorocholine PET/CT for parathyroid imaging in patients with primary hyperparathyroidism.
    Nucl Med Commun. 2020 May 21. doi: 10.1097/MNM.0000000000001217.
    PubMed     Abstract available


  220. BROWN PH, Carter JR, Moyade P, Mohammed M, et al
    Real-world experience of the role of 18F FDG PET-computed tomography in chronic spinal implant infection.
    Nucl Med Commun. 2020 May 15. doi: 10.1097/MNM.0000000000001211.
    PubMed     Abstract available


  221. AKIN M, Orguc S, Aras F, Kandiloglu AR, et al
    Molecular subtypes of invasive breast cancer: correlation between PET/computed tomography and MRI findings.
    Nucl Med Commun. 2020 May 15. doi: 10.1097/MNM.0000000000001220.
    PubMed     Abstract available


  222. VAN DER ZANT FM, Maurits W, Lazarenko SV, Broos WAM, et al
    Relation between pharmacological stress ECG, 13NH3-PET/CT outcome and the occurrence of cardiac events during follow-up in women with chest pain.
    Nucl Med Commun. 2020 May 15. doi: 10.1097/MNM.0000000000001212.
    PubMed     Abstract available


  223. BIEG C, Mongelli F, Peterli R, Chirindel AF, et al
    Simplified dual time point FDG-PET/computed tomography for determining dignity of pancreatic lesions.
    Nucl Med Commun. 2020 May 8. doi: 10.1097/MNM.0000000000001191.
    PubMed     Abstract available


  224. GAZZILLI M, Albano D, Durmo R, Cerudelli E, et al
    Improvement of diagnostic accuracy of 18fluorine-fluorodeoxyglucose PET/computed tomography in detection of infective endocarditis using a 72-h low carbs protocol.
    Nucl Med Commun. 2020 May 8. doi: 10.1097/MNM.0000000000001208.
    PubMed     Abstract available


  225. MACNAB MF, Biggans TJ, Mckiddie FI, Pether MI, et al
    Detectability of small objects in PET/computed tomography phantom images with Bayesian penalised likelihood reconstruction.
    Nucl Med Commun. 2020 May 8. doi: 10.1097/MNM.0000000000001204.
    PubMed     Abstract available


  226. JIMENEZ LONDONO GA, Garcia Vicente AM, Noriega Alvarez E, Pena Pardo FJ, et al
    18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies.
    Nucl Med Commun. 2020 May 8. doi: 10.1097/MNM.0000000000001189.
    PubMed     Abstract available


  227. ZUCKIER LS, Gordon SR
    COVID-19 in the Nuclear Medicine Department, be prepared for ventilation scans as well!
    Nucl Med Commun. 2020;41:494-495.
    PubMed    


  228. TSUCHIYA J, Yoneyama T, Ohtake M, Tateishi K, et al
    Redox reaction and clinical outcome of primary diffuse large B-cell lymphoma of the central nervous system: Prognostic role of metabolic and textural parameters of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/computed tomography in a small patie
    Nucl Med Commun. 2020 May 1. doi: 10.1097/MNM.0000000000001197.
    PubMed     Abstract available


  229. CASTELLO A, Riva M, Fernandes B, Bello L, et al
    The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomas.
    Nucl Med Commun. 2020 May 1. doi: 10.1097/MNM.0000000000001202.
    PubMed     Abstract available


  230. PIZZUTO DA, Husmann L, Stolzmann P, Meerwein C, et al
    Fluoro-deoxy-glucose uptake in the mylohyoid muscle: a common misconception.
    Nucl Med Commun. 2020;41:452-458.
    PubMed     Abstract available


  231. PANDEY AK, Santosh Y, Sharma PD, Yadav D, et al
    Restoration of I-131 whole body image using a Wiener filter.
    Nucl Med Commun. 2020;41:426-435.
    PubMed     Abstract available


    April 2020
  232. BUSCOMBE JR, Notghi A, Croasdale J, Pandit M, et al
    COVID-19: guidance for infection prevention and control in nuclear medicine.
    Nucl Med Commun. 2020 Apr 15. doi: 10.1097/MNM.0000000000001206.
    PubMed     Abstract available


  233. KULKARNI SC, Padma S, Shanmuga Sundaram P
    In the evaluation of patients with skull base osteomyelitis, does 18F-FDG PET CT have a role?
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001187.
    PubMed     Abstract available


  234. ZHANG J, Ma G, Cheng J, Song S, et al
    Diagnostic classification of solitary pulmonary nodules using support vector machine model based on 2-[18F]fluoro-2-deoxy-D-glucose PET/computed tomography texture features.
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001193.
    PubMed     Abstract available


  235. FRAIOLI F, Shankar A, Hyare H, Ferrazzoli V, et al
    The use of multiparametric 18F-fluoro-L-3,4-dihydroxy-phenylalanine PET/MRI in post-therapy assessment of patients with gliomas.
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001184.
    PubMed     Abstract available


  236. KIM DH, Kim SJ
    Diagnostic performances of F-18 FDG PET or PET/CT for detection of post-transplant lymphoproliferative disorder: a systematic review and meta-analysis.
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001194.
    PubMed     Abstract available


  237. SHAO X, Chen Y, Shao X, Wang S, et al
    Gender differences in brown adipose tissue-related brain functional networks: an 18F-FDG-PET study.
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001190.
    PubMed     Abstract available


  238. TALAAT OM, Ali IM, Abolyazid SM, Abdelmaksoud B, et al
    Long-term scintigraphic and clinical follow up in patients with differentiated thyroid cancer and iodine avid bone metastases.
    Nucl Med Commun. 2020;41:327-335.
    PubMed     Abstract available


  239. CHEN YC, Han DY, Chang CC, Su CH, et al
    The establishment and application of sialoscintigraphic reference values from patients with obstructive sialadenitis.
    Nucl Med Commun. 2020;41:308-313.
    PubMed     Abstract available


  240. WANG L, Wu Z, Wang A, Jin X, et al
    Effects of nucleo(s)tide analogs therapy on chronic hepatitis B as evaluated by hepatosplenic radionuclide angiography.
    Nucl Med Commun. 2020;41:314-319.
    PubMed     Abstract available


    March 2020
  241. GUPTA A, Patel C, Gupta SK, Ramakrishnan S, et al
    Myocardial perfusion abnormalities in Eisenmenger syndrome.
    Nucl Med Commun. 2020;41:206-211.
    PubMed     Abstract available


  242. POURHASSAN SHAMCHI S, Zirakchian Zadeh M, Ostergaard B, Kim J, et al
    Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation.
    Nucl Med Commun. 2020;41:288-293.
    PubMed     Abstract available


  243. ITO T, Onoguchi M, Okuda K, Shibutani T, et al
    Study of novel deformable image registration in myocardial perfusion single-photon emission computed tomography.
    Nucl Med Commun. 2020;41:196-205.
    PubMed     Abstract available


  244. BHURE U, Roos JE, Perez-Lago MDS, Strobel K, et al
    Single-photon emission computed tomography/computed tomography arthrography of wrist, ankle, and knee joints.
    Nucl Med Commun. 2020;41:182-188.
    PubMed     Abstract available


    February 2020
  245. RADULOVIC M, Jankovic MM, Durutovic O, Sobic-Saranovic DP, et al
    Interobserver reproducibility of mercaptoacetyltriglicine renography in children and adults with suspected obstruction: parameters of drainage and function calculated by International Atomic Energy Agency software.
    Nucl Med Commun. 2020;41:96-103.
    PubMed     Abstract available


  246. CHIARAVALLOTI A, Barbagallo G, Castellano AE, Ricci M, et al
    [18F] FBB cortical uptake is not related to the age of onset of Alzheimer's disease.
    Nucl Med Commun. 2020;41:175-180.
    PubMed     Abstract available


  247. OLIVEIRA-SANTOS M, McMahon G, Castelo-Branco M, Silva R, et al
    Renal artery wall 18F-NaF activity and glomerular filtration rate: an exploratory analysis in a high cardiovascular risk population.
    Nucl Med Commun. 2020;41:126-132.
    PubMed     Abstract available


  248. JUWEID ME, Omari Y, Khawaja N, AlSharif A, et al
    Use of pinhole dual-phase Tc-99m sestamibi vs combined Tc-99m sestamibi and Tc-99m pertechnetate scintigraphy in patients with hyperparathyroidism where single-photon emission computed tomography/computed tomography is unavailable.
    Nucl Med Commun. 2020;41:87-95.
    PubMed     Abstract available


    January 2020
  249. FILIPPI L, Di Costanzo GG, Tortora R, Pelle G, et al
    Prognostic value of neutrophil-to-lymphocyte ratio and its correlation with fluorine-18-fluorodeoxyglucose metabolic parameters in intrahepatic cholangiocarcinoma submitted to 90Y-radioembolization.
    Nucl Med Commun. 2020;41:78-86.
    PubMed     Abstract available


    December 2019
  250. GUPTA P, Murthy V, Agarwal A, Maitre M, et al
    68Ga-prostate-specific membrane antigen PETCT-based response to androgen deprivation therapy in patients with prostate cancer.
    Nucl Med Commun. 2019;40:1283-1288.
    PubMed     Abstract available


  251. OKUDAN B, Seven B, Coskun N, Albayrak A, et al
    Comparison between single-photon emission computed tomography/computed tomography and ultrasound in preoperative detection of parathyroid adenoma: retrospective review of an institutional experience.
    Nucl Med Commun. 2019;40:1211-1215.
    PubMed     Abstract available


  252. GUPTA V, Verma R, Ranjan R, Belho ES, et al
    Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia.
    Nucl Med Commun. 2019;40:1275-1282.
    PubMed     Abstract available


  253. KIM H, Oh M, Oh JS, Moon H, et al
    Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Nucl Med Commun. 2019;40:1216-1223.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: